Literature DB >> 30665549

Non-surgical management of primary hyperparathyroidism.

Filomena Cetani1, Federica Saponaro1, Claudio Marcocci2.   

Abstract

The purpose of this chapter is to discuss the options available for patients with primary hyperparathyrodism (PHPT) not undergoing parathyroidectomy (PTx). Adequate hydration should be recommended in all patients. Calcium intake should not be restricted and vitamin D deficiency should be corrected aiming at a serum concentration of 25OHD of >20 ng/mL or even higher (>30 ng/mL according to some opinion leaders). Pharmacologic therapy is not an alternative to PTx and could be considered in patients who meet the surgical criteria but unwilling to undergo PTx, as well as in patients with an increased risk of surgery or failed surgery. Targeted therapy includes antiresorptive drugs for skeletal protection and cinacalcet for lowering serum calcium. Combined therapy can be an option when appropriate. Pregnant women should be treated conservatively (hydration) and surgery, if needed, performed in the second trimester of pregnancy. Severe hypercalcemia is a life-threatening condition and requires immediate intensive treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antiresorptive drugs; cinacalcet; hypercalcemia; parathyroid cancer; pregnancy; vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30665549     DOI: 10.1016/j.beem.2018.09.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

Review 1.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

2.  Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia.

Authors:  Yulong Li; Chris Y Fan; Andrea Manni; William F Simonds
Journal:  BMJ Case Rep       Date:  2020-04-28

Review 3.  Recent advances in the understanding and management of primary hyperparathyroidism.

Authors:  Melanie Goldfarb; Frederick R Singer
Journal:  F1000Res       Date:  2020-02-25

4.  Hyperparathyroidism in pregnancy.

Authors:  Catherine Davis; Tanya Nippita
Journal:  BMJ Case Rep       Date:  2020-02-16

5.  Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism.

Authors:  J G Timmons; R Manners; M Bailey; C McDougall
Journal:  Hormones (Athens)       Date:  2021-04-21       Impact factor: 2.885

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.